These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1316232)
1. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Rao MS; Subbarao V; Yeldandi AV; Reddy JK Cancer Res; 1992 May; 52(10):2977-9. PubMed ID: 1316232 [TBL] [Abstract][Full Text] [Related]
2. Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats. Rao MS; Subbarao V; Kumar S; Yeldandi AV; Reddy JK Jpn J Cancer Res; 1992 Nov; 83(11):1179-83. PubMed ID: 1336491 [TBL] [Abstract][Full Text] [Related]
3. Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas. Ledda-Columbano GM; Perra A; Loi R; Shinozuka H; Columbano A Cancer Res; 2000 Feb; 60(3):603-9. PubMed ID: 10676643 [TBL] [Abstract][Full Text] [Related]
4. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433 [TBL] [Abstract][Full Text] [Related]
5. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989 [TBL] [Abstract][Full Text] [Related]
6. Effect of castration on dehydroepiandrosterone-induced hepatocarcinogenesis in male rats. Rao MS; Kashireddy P Anticancer Res; 2002; 22(3):1409-11. PubMed ID: 12168817 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121 [TBL] [Abstract][Full Text] [Related]
8. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS; Cattley RC; Conway JG; Popp JA Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084 [TBL] [Abstract][Full Text] [Related]
9. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators. Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y J Environ Pathol Toxicol Oncol; 1992; 11(3):145-9. PubMed ID: 1625184 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation. Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639 [TBL] [Abstract][Full Text] [Related]
11. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats. Ohshima M; Ward JM; Brennan LM; Creasia DA J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Hayashi F; Tamura H; Yamada J; Kasai H; Suga T Carcinogenesis; 1994 Oct; 15(10):2215-9. PubMed ID: 7955056 [TBL] [Abstract][Full Text] [Related]
13. Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase. Rao MS; Tatematsu M; Subbarao V; Ito N; Reddy JK Cancer Res; 1986 Oct; 46(10):5287-90. PubMed ID: 2875789 [TBL] [Abstract][Full Text] [Related]
14. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model. Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317 [TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
16. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model. Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703 [TBL] [Abstract][Full Text] [Related]
17. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Metzger C; Mayer D; Hoffmann H; Bocker T; Hobe G; Benner A; Bannasch P Toxicol Pathol; 1995; 23(5):591-605. PubMed ID: 8578102 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Rao MS; Lalwani ND; Watanabe TK; Reddy JK Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393 [TBL] [Abstract][Full Text] [Related]
19. Sex differences in dehydroepiandrosterone-induced hepatocarcinogenesis in the rat. Rao MS; Subbarao V Cancer Lett; 1998 Mar; 125(1-2):111-6. PubMed ID: 9566704 [TBL] [Abstract][Full Text] [Related]
20. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator. Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]